Financials data is unavailable for this security.
Cash flow in CNYView more
In 2023, Beijing Luzhu Biotechnology Co Ltd increased its cash reserves by 273.89%, or 188.92m. Cash Flow from Financing totalled 273.17m or -- of revenues. In addition the company used 189.95m for operations while cash from investing totalled 98.58m.
Cash flow per share | -1.38 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 5.05 |
---|---|
Tangible book value per share | 5.03 |
More ▼
Balance sheet in CNYView more
Current ratio | 5.97 |
---|---|
Quick ratio | 5.91 |
Total debt/total equity | 0.0305 |
---|---|
Total debt/total capital | 0.0296 |
More ▼